Francisco D. Salva

Insider Reports History

Location: Santa Clara, CA
Reporting signature: /s/ Francisco D. Salva
Transaction evidence: Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Francisco D. Salva:

Form 4 holding President and CEO, Director

Azitra, Inc.

Security class: Series B Warrants
Shares / value: 4,064,050
Estimated value
Report date: 18 Mar 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding President and CEO, Director

Azitra, Inc.

Security class: Series C Warrants
Shares / value: 4,064,050
Estimated value
Report date: 18 Mar 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding President and CEO, Director

Azitra, Inc.

Security class: Stock Options (Right To Buy)
Shares / value: 220,879
Estimated value
Report date: 20 Apr 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Vincerx Pharma, Inc.

Security class: Stock Option (right to buy)
Shares / value: 15,000
Estimated value
Report date: 23 May 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding President and CEO, Director

Azitra, Inc.

Security class: Series A Convertible Non-Redeemable Preferred Stock
Shares / value: 500
Estimated value
Report date: 18 Mar 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Francisco D. Salva

4 AZTR

Azitra, Inc.

Report period: 20 Apr 2026
Transactions: 1
Transaction value: $0
Filing time: 22 Apr 2026, 17:30
Role: President and CEO, Director
Next action: Open filing details

4 AZTR

Azitra, Inc.

Report period: 18 Mar 2026
Transactions: 3
Transaction value: $0
Filing time: 20 Mar 2026, 16:30
Role: President and CEO, Director
Next action: Open filing details

4 AZTR

Azitra, Inc.

Report period: 19 Dec 2025
Transactions: 1
Transaction value: $0
Filing time: 22 Dec 2025, 17:28
Role: President and CEO, Director
Next action: Open filing details

4 VINC

Vincerx Pharma, Inc.

Report period: 23 May 2024
Transactions: 1
Transaction value: $0
Filing time: 28 May 2024, 16:38
Role: Director
Next action: Open filing details

4 AZTR

Azitra, Inc.

Report period: 13 Feb 2024
Transactions: 1
Transaction value: +$99,990
Filing time: 15 Feb 2024, 20:38
Role: President and CEO, Director
Next action: Open filing details

4 AZTR

Azitra Inc

Report period: 21 Jun 2023
Transactions: 1
Transaction value: +$25,000
Filing time: 23 Jun 2023, 20:39
Role: President and CEO, Director
Next action: Open filing details

3 AZTR

Azitra Inc

Report period: 15 Jun 2023
Transactions: 0
Transaction value: $0
Filing time: 15 Jun 2023, 17:46
Role: President and CEO, Director
Next action: Open filing details

4 VINC

Vincerx Pharma, Inc.

Report period: 25 May 2023
Transactions: 1
Transaction value: $0
Filing time: 30 May 2023, 16:05
Role: Director
Next action: Open filing details

4 VINC

Vincerx Pharma, Inc.

Report period: 26 May 2022
Transactions: 1
Transaction value: $0
Filing time: 31 May 2022, 16:06
Role: Director
Next action: Open filing details

4 VINC

Vincerx Pharma, Inc.

Report period: 13 May 2021
Transactions: 1
Transaction value: $0
Filing time: 14 May 2021, 17:23
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .